Does Helicobacter pylori eradication really reduce the risk of gastric cancer at the population level?

Gut

Volumn 62, Issue 6, 2013, Pages 950-

  Wang, Zhu ^a   Yu, Yang ^a   Yang, Wenjuan ^a   Chen, Bin ^a   Li, Xiao ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; ENDOSCOPIC SURGERY; ERADICATION THERAPY; HELICOBACTER INFECTION; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; RISK REDUCTION; STOMACH CANCER; STOMACH CARCINOMA;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 84876888271     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303472     Document Type: Letter

References (4)

1. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
2. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-94. (Pubitemid 38082812)
3. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392-7.
4. Maehata Y, Nakamura S, Fujisawa K, et al. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastroint Endosc 2012;75:39-46.